Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
57 participants
INTERVENTIONAL
2012-04-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study of Demand Valve Oxygen Inhalation Therapy for Cluster Headache
NCT01298921
Continuous Positive Airway Pressure as a Potential New Treatment for Cluster Headache
NCT03397563
Circadian Rhythm and Attack-timing in Episodic Cluster Headache Patients in- and Outside of Bout: an Actigraphic Study
NCT02853487
Migraine With Aura Inducing Characteristics and Effects on the Cerebral Arteries and Blood Flow by Hypoxia
NCT01896167
Sphenopalatine Ganglion Stimulation for the Acute Treatment of Cluster Headache
NCT01255813
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mask 1
Open Hudson Mask
Mask type 1 oxygen
Mask 2
Cluster headache mask with 3 L reservoir
Mask type 2 with oxygen
Mask 3
Mask 3
Mask type 3 oxygen
Carnét oxygen demand valve
mask type 3 oxygen
Mask 3, placebo
Carnét oxygen demand valve
mask type 3 placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Open Hudson Mask
Mask type 1 oxygen
Cluster headache mask with 3 L reservoir
Mask type 2 with oxygen
Mask 3
Mask type 3 oxygen
Carnét oxygen demand valve
mask type 3 oxygen
Carnét oxygen demand valve
mask type 3 placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* regular occurance of attacks and cluster for 2 years
* 2-8 attacks / day
* cluster periods of over 14 days
* duration of current cluster period max 14 days
* ability to differentiate between attacks of CH and other forms of headache
Exclusion Criteria
* pregnancy or breastfeeding women
* serious somatic or psychiatric disease
* COLD
* chronic or primary or secondary headache \> 14 days / month other than CH
* alcohol abuse
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mads Barløse
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mads Barløse
MD, principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Danish Headache Center
Glostrup Municipality, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-2-2011-163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.